Vineet Gupta

机构：The University of Texas Medical Branch at Galveston · ORCID：0000-0001-6987-2550

发表论文 154 篇 · 总被引 7816 次 · h-index 38

代表论文

• Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study (2024 · ˜The œLancet. Gastroenterology & hepatology · 被引 282)
• Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet · 被引 132)
• Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity (2023 · Cancer Cell · 被引 97)
• Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer (2023 · Journal for ImmunoTherapy of Cancer · 被引 37)
• Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer. (2023 · Journal of Clinical Oncology · 被引 24)
• Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma (2023 · Cureus · 被引 12)